About Hepatorenal Syndrome
Hepatorenal syndrome is kidney damage that occurs as a result of severe liver disease. It is characterized by rapid onset of kidney disease symptoms and may even lead to kidney failure.
Unlike primary kidney disease, people with hepatorenal syndrome do not typically have symptoms such as protein or blood in the urine, and scans of the kidneys may appear normal. It is important to note that not every case of kidney disease in people with liver disease is hepatorenal syndrome, and people without liver disease can develop other forms of kidney disease.
The exact cause of Hepatorenal Syndrome is unknown, but it occurs in people with chronic and severe decompensated liver disease. This means that anyone with liver disease is at risk, especially those with severe unmanaged liver disease. Some of the causes are:
- Viral hepatitis is a common cause in developing countries
- Chronic alcohol use disorder (which can lead to cirrhosis)
- Drug-induced liver injuries
- Non alcoholic fatty liver disease
- Portal vein thrombosis (a blood clot in the vein that leads to the liver)
When it comes to risk factors, there are both non-modifiable and modifiable factors to consider. Non-modifiable risk factors are factors that cannot be altered. In the case of Hepatorenal Syndrome, non-modifiable risk factors include:
- Increasing age
- Genetic predispositions such as a positive family history of liver disease or related conditions
On the other hand, modifiable risk factors are largely related to individual habits and lifestyle choices that can be influenced by cultural and social factors. Some important components of modifiable risk factors for Hepatorenal Syndrome include:
- Poor dietary habits
- Low physical activity levels and their subsequent complications
- Smoking
In general, it is recommended to maintain a healthy weight, engage in regular physical activity, and follow a healthy diet to reduce the risk of developing Hepatorenal Syndrome. By making these lifestyle changes, individuals can potentially modify their risk factors and improve their overall health.
Early symptoms of Hepatorenal Syndrome may include:
- Tenderness in the upper right side where the liver is
- Swelling in the abdomen or stomach
- Jaundice (which causes yellowing of the skin or eyes)
- Dark urine
- Enlarged spleen
Other common symptoms that may occur with later stages, progression, or higher severity of Hepatorenal Syndrome include:
- Reduced urine output
- Feeling sick or tired
- Stomach pain
- Swelling throughout the body
- Narrowing of blood vessels that supply the kidney can lead to decreased blood flow to the organ, impairing its function
To diagnose Hepatorenal Syndrome, doctors commonly perform the following examinations, tests, and procedures:
- Physical examination: Doctors will conduct a physical examination to look for signs of liver disease, which is often associated with Hepatorenal Syndrome.
- Laboratory tests: Doctors will order laboratory tests to help diagnose Hepatorenal Syndrome. One common test is creatinine testing, as high levels of creatinine in the blood are often seen in people with hepatorenal disease. Additionally, doctors may order tests to identify liver disease with portal hypertension, which is high blood pressure in the portal vein leading to the liver. They may also perform tests to rule out other kidney diseases and other diseases that may have similar symptoms.
In addition to these common diagnostic tests, there are additional examinations, tests, and procedures that can be used to determine the stage or severity of Hepatorenal Syndrome:
- Imaging tests: Doctors may use imaging tests such as ultrasounds or CT scans to assess the condition of the liver and kidneys and identify any abnormalities.
- Kidney function tests: These tests can provide more detailed information about how well the kidneys are functioning. They may include blood tests and urine tests.
- Renal biopsy: In some cases, doctors may perform a renal biopsy, which involves taking a small sample of kidney tissue for analysis. This can help confirm the diagnosis and provide information about the severity of the condition.
The goals of treatment for Hepatorenal Syndrome are to improve kidney function, manage complications, and prolong the person's life. While there is no cure for Hepatorenal Syndrome, there are treatment options available that can help slow down the progression of the syndrome and reduce complications.
- Medications: Medications called vasoconstrictors, such as terlipressin, are often used to improve blood flow to the kidneys, and albumin may be administered to help maintain fluid balance in the body.
- Some medications can worsen kidney function, so it is important to identify and discontinue any drugs that may have this effect.
These are therapeutic procedures that may be recommended for the treatment of Hepatorenal Syndrome:
- Paracentesis: This is a surgical procedure in which excess fluid in the abdomen is removed. By reducing abdominal fluid, paracentesis can help relieve pressure on the kidneys and improve kidney function.
- Transjugular intrahepatic portosystemic shunt (TIPS): TIPS is a procedure in which a small tube is placed to create a pathway between the portal vein (which carries blood from the intestines to the liver) and one of the hepatic veins (which carry blood from the liver back to the heart). TIPS helps reduce portal hypertension (high blood pressure in the portal vein) and decreases stress on the kidneys.
- Molecular adsorbent recirculating system (MARS): MARS is an experimental dialysis technique that helps remove toxins from the blood. It works by circulating the patient's blood through a device that filters out waste products before returning it to the body. MARS can help improve kidney function in people with Hepatorenal Syndrome.
- Surgery: While a liver transplant is the only treatment that can cure Hepatorenal Syndrome, not all individuals are suitable candidates for this procedure. This option is typically reserved for individuals who meet specific criteria and have access to a suitable donor organ. There is often a long waiting list.
- In some cases, kidney failure may require a person to undergo both a kidney transplant and a liver transplant.
It's important to note that treatment options may vary depending on individual circumstances, such as overall health, severity of liver disease, and response to previous treatments. Therefore, it's crucial for individuals with Hepatorenal Syndrome to work closely with their healthcare team to determine the most appropriate treatment plan for their specific needs.
The natural progression of Hepatorenal Syndrome can vary depending on the type of the syndrome. Type 1 Hepatorenal Syndrome typically presents with a rapidly progressive decline in renal function, while Type 2 progresses more slowly over weeks to months.
The prognosis for both types is generally poor, with survival ranging from months for Type 2 to weeks to months for Type 1.
Hepatorenal Syndrome often occurs in individuals with advanced chronic liver disease, and it is associated with other complications such as:
- Ascites (abdominal fluid buildup): This occurs when liver failure causes pressure changes and fluid leaks into the abdominal cavity, a common complication seen in hepatorenal syndrome as kidney function worsens.
- Esophageal varices (enlarged veins in the esophagus): These swollen veins develop due to increased pressure in the veins connected to the liver and can rupture, further complicating hepatorenal syndrome by worsening overall health and blood circulation.
- Hepatic encephalopathy (brain dysfunction due to liver disease): This condition occurs when toxins build up in the blood due to liver failure, and it often coincides with hepatorenal syndrome as both conditions reflect severe liver dysfunction.
These complications commonly coexist with Hepatorenal Syndrome and can further impact the overall health and well-being of individuals. It's important to remember that treatment plans may vary for each individual. Consulting with a healthcare professional is crucial for personalized advice and guidance to prevent complications of Hepatorenal Syndrome.